Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks. - Wikidata - awgldk - TriplyDB

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

http://www.wikidata.org/entity/Q35097063

about

Tumor Suppressor Genes within Common Fragile Sites Are Active Players in the DNA Damage Response WWOX, the chromosomal fragile site FRA16D spanning gene: its role in metabolism and contribution to cancer Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells Versatile communication strategies among tandem WW domain repeats WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response.The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.Advancement and applications of peptide phage display technology in biomedical science Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.Alteration of WWOX in human cancer: a clinical view.Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.Regulation of cell signaling and apoptosis by tumor suppressor WWOX.Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability.The fragile site WWOX gene and the developing brain.The tumor suppressor WW domain-containing oxidoreductase modulates cell metabolism.WWOX: a fragile tumor suppressor.The E3 ligase Itch in immune regulation and beyond.Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis.Genomics of Esophageal Cancer and Biomarkers for Early Detection.Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation.Peptides and peptidomimetics as regulators of protein-protein interactions.WWOX loss activates aerobic glycolysis.WWOX modulates the ATR-mediated DNA damage checkpoint response WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation.WWOX guards genome stability by activating ATM.T538 phosphorylation, Pin-ing p63-Itch stability.Tumor suppressor WWOX moderates the mitochondrial respiratory complex.WWOX controls hepatic HIF1α to suppress hepatocyte proliferation and neoplasia.Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions Modeling WWOX Loss of Function : What Have We Learned?Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer

P2860

Q28070247-13B10D30-020B-47C7-B176-D7A8C15EFAE5 Q28080638-07008053-F0F6-4148-AAD6-FAA4EB25A607 Q28080922-E44904D7-F8AF-45FC-9685-81692A12CD52 Q28087599-CBBF289F-E075-4A52-B3B5-DCABE68250E5 Q34120466-60932FFA-C252-46D7-89CD-65DEF3894084 Q34480661-2BF837BA-8410-44F9-9E47-905F8024F84D Q34786592-7B497028-7CF6-4830-87C8-6B74219AD9C2 Q35217707-C235C1CA-912C-488F-A60E-EEA655008E8B Q35898339-E89BBFE9-0457-43F9-A124-5A27F4EBFF8C Q36877896-CC333671-7DE4-477F-829D-CF1C60968956 Q37071040-2015E9F8-9A71-405D-9221-3BB4D5329B0A Q37071045-2F2A7C33-B1F2-4979-B609-D0C9EF0CBECE Q37071049-88EBD3F2-9921-414D-8C35-28FC5CF5C5F2 Q37071059-CC5E993D-CDBF-440C-B9F8-C8550AAC93BC Q38253201-DF1A896E-4FAA-4086-81CA-728C121C621B Q38270425-3FA98C87-7D4E-4FA5-810C-935556963856 Q38285824-F247ACA0-7B8B-4029-899C-C43A1F8CD8FD Q38299692-82722AE6-60D4-4A2F-BE3F-695452EFA979 Q38530613-1D3376C4-FC0C-4FD5-BF58-BD750152B839 Q38817885-39173C2D-E30E-4016-B887-4BC6D50CF14A Q38940530-A3BC486F-54B0-4334-A7F5-5256A7FF2CB2 Q38976539-399E768A-0648-45FD-A48F-AFB7BC1CE87C Q39072845-C3567164-1153-4D2E-A2AA-D2EBEF9BB55A Q39679531-5CCB5303-15A1-4D43-B08D-80D29C013968 Q39996960-AC5A28A0-087F-4182-93F7-22BACBB8EBC0 Q41929086-1BE908D0-50CE-49F5-B918-63F702D22A80 Q41952743-CE558F7B-5656-4F78-AA4E-7708E9AE872B Q43207078-88DF80BD-90CA-43AD-AD79-E11B0DA7EA2F Q46666593-382FF5C1-1A94-4594-B8C1-DA9494DF7C70 Q55003004-6B7A334C-D343-4793-B257-BA13CF1F36C3 Q57107482-CB90C901-393D-4548-A995-29F2C2A54A23 Q58123045-A31CB338-CB12-44A4-BFD6-5E247ABCBF62 Q58799648-D6070EBF-0835-4980-AAAE-8D75B4F08ACD

P2860

Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.

http://www.wikidata.org/entity/Q35097063

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Characterizing WW domain inter ...... on with multiprotein networks.

@ast

Characterizing WW domain inter ...... on with multiprotein networks.

@en

type

label

Characterizing WW domain inter ...... on with multiprotein networks.

@ast

Characterizing WW domain inter ...... on with multiprotein networks.

@en

prefLabel

Characterizing WW domain inter ...... on with multiprotein networks.

@ast

Characterizing WW domain inter ...... on with multiprotein networks.

@en

P1433

Q35097063-FF75A05D-4354-427D-99E2-10138374CDEB

P1476

Q35097063-3AEC4E5A-A104-419F-B55E-5E09A28AF95F

P2093

Q35097063-0F535CBC-974F-46E2-ACD0-C5D325A5DB9E

Q35097063-2A369E63-01A6-4F7C-B4CD-7E861055C53C

Q35097063-38F573F1-F7E7-4F92-A82D-F2247AA32306

Q35097063-53F9458A-181E-4437-81B0-63FFE78EA167

Q35097063-A5B8DDB5-841C-43B5-8B59-0C1BBD1929D5

Q35097063-AF7AE2C6-AD81-4A5E-BD82-F0152DAB7356

Q35097063-B8C48F4F-BBC6-4B04-9811-ACC6B1D37A37

Q35097063-DDDE67B3-2B0E-4804-94E4-BCFC8CC913DE

Q35097063-E351C3BB-C0E7-41E7-A642-B00AF5CE3281

Q35097063-E76E6F04-A14A-46F5-8524-797A50B4292E

P2860

Q35097063-02063DEE-E06A-479D-9220-6BC608C96940

Q35097063-0A9D6D58-06B2-40BC-B7E1-0161A95158B2

Q35097063-0C08F20C-1C06-453F-A5F8-BDA227DAC1FA

Q35097063-10653C6C-1D3C-4A39-95DB-97A414C1727B

Q35097063-1BB6C597-9568-44CD-B78A-687F48CCA7E0

Q35097063-1BE4E81B-ABA1-4A6C-B488-3854FD8EFE1E

Q35097063-230F9234-9703-408B-9ED7-0DFB7098D468

Q35097063-2A1CF958-CC34-4158-B15A-6A125C5A9BD4

Q35097063-34F3A4F3-5EAC-43B1-99A2-24D11FDB7A2D

Q35097063-3603044E-ADA8-4F5A-8BBD-B26F775B3854

P304

Q35097063-6675C595-F26C-41A0-8D02-48DDD18D9D7F

P31

Q35097063-24AA2A3A-98B0-4A0B-A4BD-301A44501822

P356

Q35097063-EA8617AF-EE2A-4457-96C8-8FA78E13B409

P407

Q35097063-9B2B1842-688A-4C32-8512-E916335AFA4E

P433

Q35097063-C52579E0-B1EC-42F6-BE7E-08A33FCA179A

P478

Q35097063-4A268F16-809C-4ADF-B695-31DCDD2E89DA

P50

Q35097063-8F35470C-7282-4CF3-987A-CAACEF3B67CC

P577

Q35097063-CBACB14C-442C-4945-9C5E-80DC988BC0CA

P698

Q35097063-4BB7584D-A3DE-4BC0-BF47-22215A8FF4C5

P932

Q35097063-006D5F82-9CC4-4E2D-9D20-7137CECF39B4

P356

JBC.M113.506790

P1433

Journal of Biological Chemistry

P1476

Characterizing WW domain inter ...... on with multiprotein networks.

@en

P2093

Haiming Huang

http://www.w3.org/2001/XMLSchema#string

Marius Sudol

http://www.w3.org/2001/XMLSchema#string

Mohammad Abu-Odeh

http://www.w3.org/2001/XMLSchema#string

Philip M Kim

http://www.w3.org/2001/XMLSchema#string

Rami I Aqeilan

http://www.w3.org/2001/XMLSchema#string

Sachdev Sidhu

http://www.w3.org/2001/XMLSchema#string

Suhaib K Abdeen

http://www.w3.org/2001/XMLSchema#string

TaeHyung Kim

http://www.w3.org/2001/XMLSchema#string

Tomer Bar-Mag

http://www.w3.org/2001/XMLSchema#string

Zaidoun Salah

http://www.w3.org/2001/XMLSchema#string

P2860

Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

The ubiquitin-protein ligase Itch regulates p73 stability

Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal

WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function

Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands

Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules

WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins

P304

8865-8880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M113.506790

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24550385

http://www.w3.org/2001/XMLSchema#string

P932

3979411

http://www.w3.org/2001/XMLSchema#string